62例弥漫性低级别胶质瘤患者在非治疗且无进展期的健康相关生活质量:一项横断面研究
该横断面队列研究纳入62例处于临床和影像学监测期的弥漫性低级别胶质瘤患者,采用EORTC QLQ-C30、BN-20及医院焦虑抑郁量表评估健康相关生活质量,并与常模人群比较。结果显示患者认知、情绪、角色和社会功能显著低于常模,疲劳、焦虑、抑郁和睡眠障碍常见;清醒手术和保持高卡氏功能状态是更好总体生活质量的独立预后因素,放疗与生活质量恶化相关。
要点
- 低级别胶质瘤患者在非治疗无进展期仍报告多个生活质量维度明显受限。
- 与常模相比,患者认知、情绪、角色和社会功能显著降低。
- 清醒手术和保持高卡氏功能状态与更好总体生活质量独立相关,放疗与生活质量恶化相关。
核心结论
- 尽管处于非治疗且无进展阶段,低级别胶质瘤患者在多个健康相关生活质量子量表上报告明显受限。
- 研究强调生活质量评估不应仅在诊断时或积极治疗阶段进行。
- 需要进一步研究开发更适合的生活质量评估工具。
研究设计与样本
- 横断面队列研究,纳入62例弥漫性低级别胶质瘤患者。
- 使用欧洲癌症研究与治疗组织QLQ-C30、BN-20及医院焦虑抑郁量表评估健康相关生活质量。
- 将QLQ-C30和医院焦虑抑郁量表平均分与常模人群比较,并采用一般线性模型多变量方差分析探讨生活质量与独立因素的关联。
主要发现
- 与常模人群相比,低级别胶质瘤患者报告认知、情绪、角色和社会功能在统计学和临床上显著降低。
- 疲劳、焦虑、抑郁和睡眠障碍常被报告。
- 清醒手术和保持高卡氏功能状态是更好总体健康相关生活质量的独立预后因素。
- 放疗与健康相关生活质量恶化相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究开发更适合的健康相关生活质量评估工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Few studies have evaluated the health-related quality of life (HRQoL) of patients with diffuse low-grade glioma (LGG) during a clinical and radiological monitoring period. We report a cross sectional cohort study of HRQoL in patients with LGG and compare the results with normative population data. We then explore factors associated with HRQoL. METHODS: We used the European Organisation for Research and Treatment of Cancer QLQ-C30, BN-20 and the Hospital Anxiety and Depression Scale (HADS) to evaluate HRQoL. Averaged QLQC30 and HADS scores were compared with scores of a normative population. A general linear model multivariate analysis of variance was used to investigate the association between HRQoL and independent factors. RESULTS: A total of 62 patients with LGG completed HRQoL questionnaires. Compared with a normative population, LGG patients reported statistical and clinically significant lower cognitive, emotional, role and social functioning. Fatigue, anxiety, depression and sleep disturbances were frequently reported. Awake surgery and preserved high Karnofsky Performance Status were found to be independent prognostic factors for better global HRQoL, while radiotherapy was associated with worsened HRQoL. CONCLUSION: Despite a non-therapeutic and progression free phase, LGG patients report noticeable limitations in several HRQoL subscales. Our study highlights the importance of HRQoL assessment not only at diagnosis or during active therapeutic stage. Further studies are needed to develop better adapted tools of HRQoL assessment.
引用
- Obara T, Blonski M, Forest-Dodelin M, et al. Health-related quality of life in 62 patients with diffuse low-grade glioma during a non-therapeutic and progression-free phase: a cross-sectional study. J Neurooncol. 2024. PMID: 39680337. doi:10.1007/s11060-024-04888-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。